Trial intelligence / Profile preview

Effects of naproxen, diclofenac and piroxicam on mandibular joint pain

IRCT20210807052101N1Phase 3Completed

Sponsor
Rafsanjan University of Medical Sciences
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of naproxen, diclofenac and piroxicam in temporomandibular disorder (TMD) (3 arms), sponsored by Rafsanjan University of Medical Sciences. Started Sep 2015; status: completed.

02

Drugs

naproxendiclofenacpiroxicam
03

Conditions

temporomandibular disorder (TMD)

Beyond the preview

Go deeper on IRCT20210807052101N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210807052101N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call